For: | Kaneko R, Nakazaki N, Omori R, Yano Y, Ogawa M, Sato Y. Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience. World J Hepatol 2018; 10(1): 88-94 [PMID: 29399282 DOI: 10.4254/wjh.v10.i1.88] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v10/i1/88.htm |
Number | Citing Articles |
1 |
Hafiza Arooba Riaz, Dur E. Nishwa, Ameer Fatima, Braira Wahid, Akhtar Ali, Babita Kumari, Muhammad Idrees. Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis. Heliyon 2023; 9(5): e16169 doi: 10.1016/j.heliyon.2023.e16169
|
2 |
Lea Merone, Sian Ashton, Andy Harris, Wanjibung Shaun Edwards, Annie Preston‐Thomas, Richard Gair, Darren B. Russell. A complex increase in hepatitis C virus in a correctional facility: bumps in the road. Australian and New Zealand Journal of Public Health 2022; 46(3): 377 doi: 10.1111/1753-6405.13238
|